Senseera
Senseera is a liquid biopsy company utilizing chromatin epigenomics to create the GEM BIOMARKERS™ platform. This platform offers non-invasive disease detection and monitoring through a simple blood test, providing detailed molecular insights for diagnosis and treatment. Its focus is on revolutionizing liver disease management and accelerating drug development in oncology and immunology.
Funding Round: Seed
Funding Amount: $7.1M
Date: 07-Jan-2025
Investors: Lightspeed Venture Partners, I-Next Capital, Lowy Medical Research Institute
Markets: Biotechnology, Diagnostics, Oncology, Immunology, Metabolic Diseases
HQ: Jerusalem, Israel
Founded: 2020
Website: https://www.senseerahealth.com/
LinkedIn: https://il.linkedin.com/company/senseerahealth
Crunchbase: https://www.crunchbase.com/organization/senseera
Leave a Comment
Comments
No comments yet.